Digirad Corporation Selects Allen & Caron for Investor Relations and Corporate Communications
May 29 2007 - 6:40AM
PR Newswire (US)
POWAY, Calif., May 29 /PRNewswire/ -- Digirad Corporation
(NASDAQ:DRAD), a leading provider of cardiovascular imaging
services and solid-state nuclear medicine imaging products,
announced it has selected Allen & Caron, Inc., headquartered in
Irvine, Calif., with offices in New York and London, as its agency
for investor relations and corporate communications. Digirad
designed and commercialized the first solid-state nuclear camera
for the detection of cardiovascular disease and other medical
conditions and now manufactures and markets a range of imaging
products and services for nuclear and ultrasound applications in
cardiology, internal medicine and general imaging. Digirad is
addressing the rising demand for imaging services and products by
independent physicians, larger multi-specialty practices, hospitals
and clinics. Chief Financial Officer Todd Clyde remarked: "As we
grow our in-office cardiovascular imaging services, add to our
solid-state nuclear products line, and drive towards sustainable
profitability, we are also looking for increased visibility in the
investment community, financial markets and media. We chose Allen
& Caron because of its solid reputation within those circles
and history of success in building investment support and enhancing
valuation. Allen & Caron President and Chief Operating Officer
Rene Caron commented: "Digirad's first-quarter shows solid results
in key performance metrics. With a sound business plan, experienced
senior management, strong balance sheet and substantial liquidity,
we feel Digirad will succeed and offers a compelling investment
opportunity." About Digirad Corporation Digirad Corporation
provides diagnostic imaging products and services to physician
offices, hospitals and other medical providers for use in
cardiology, internal medicine, and general imaging applications.
Digirad designed and commercialized the first solid-state nuclear
gamma camera for the detection of cardiovascular disease and other
medical conditions. The unique lightweight and compact design of
Digirad's cameras also allows use in small office spaces and for
mobile services. For more information, go to
http://www.digirad.com/. Digirad(R) is a registered trademark of
Digirad Corporation. About Allen & Caron Allen & Caron is a
full-service corporate, investor and marketing communications
agency serving the needs of public companies. The Allen & Caron
international client base includes emerging growth companies in a
range of industry segments. The firm has offices in Irvine,
California; New York City and London; maintains a presence in
Paris; and has an affiliate relationship with a leading investor
relations firm in Italy, which has offices in Milan and Rome.
Forward-Looking Statements Digirad cautions that statements
included in this press release that are not a description of
historical facts are forward-looking statements. You can identify
these statements by the fact that they do not relate strictly to
historical or current facts and use words such as "anticipate,"
"estimate," "expect," "project," "intend," "plan," "believe" and
other words and terms of similar meaning in connection with a
discussion of future operating or financial performance or events.
Examples of such statements include the statements regarding our
expectations that we will grow our in-office cardiovascular imaging
services, add to our solid-state nuclear products line, improve
operational efficiencies, obtain sustainable profitability,
increase visibility in the financial markets and follow a sound
business plan. The inclusion of these and other forward-looking
statements should not be regarded as a representation by Digirad
that any of its plans will be achieved. Actual results may differ
materially from those set forth in this press release due to the
risks and uncertainties inherent in Digirad's business including,
without limitation: the degree to which Digirad's camera systems
and related services will be accepted by physicians and hospitals,
some of whom may experience reliability issues or technical
problems; the ability of Digirad effectively to market, sell and
distribute its medical devices, and related services given its
limited capabilities in these areas; Digirad's ability to manage
risks relating to product liability, warranty claims, recalls,
property damage and personal injury with respect to its imaging
systems; and other risks detailed in Digirad's Securities and
Exchange Commission filings, including its Annual Report on Form
10-K and other reports filed with the Securities and Exchange
Commission. Given these uncertainties, readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date hereof. All forward-looking statements
are qualified in their entirety by this cautionary statement and
Digirad undertakes no obligation to revise or update this press
release including the forward-looking statements contained herein
to reflect events or circumstances after the date hereof or to
update the reasons actual results could differ materially from
those anticipated in these forward-looking statements, even if new
information becomes available in the future. Contact: Allen &
Caron Digirad Corporation Dan Matsui (investors) Todd Clyde Len
Hall (media) Chief Financial Officer 949 474 4300 858 726 1600
DATASOURCE: Allen & Caron CONTACT: investors, Dan Matsui, or
media, Len Hall, both of Allen & Caron, +1-949-474-4300; or
Todd Clyde, Chief Financial Officer of Digirad Corporation,
+1-858-726-1600 Web site: http://www.allencaron.com/
http://www.digirad.com/ Company News On-Call:
http://www.prnewswire.com/comp/133897.html
Copyright
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Sep 2023 to Sep 2024